News

Soleno Therapeutics to Participate in the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

September 16, 2021

REDWOOD CITY, Calif. , Sept. 16, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Announces Positive Data Showing Continued Significant Improvements in Symptoms of PWS following One Year Treatment with DCCR

September 08, 2021

Statistically significant reduction in hyperphagia and all other PWS behavioral parameters in Study C602 Statistically ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results

July 28, 2021

REDWOOD CITY, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More
Soleno – Home